< Back to ESE Press Releases
For Immediate Release
October 24th, 2006
Jennifer Miller and Steve Simpson Chair
Bio ·Life·Tech Princeton
Princeton, NJ – Early Stage East is pleased to announce that Jennifer L. Miller of Ballard Spahr Andrews & Ingersoll, LLP and Steve Simpson of Ernst & Young have been named as Co-Chairs for the fifth annual Bio · Life · Tech Princeton conference. The event will take place at the historic Nassau Inn located in the heart of downtown Princeton, NJ on Monday, December 4th.
“Bio·Life·Tech Princeton offers a great opportunity for early-stage companies to learn from other entrepreneurs and advisors, expand their professional networks, and introduce themselves to investors and venture capitalists. The knowledge they gain here will last long after the conference is over,” said Jennifer Miller, Partner with Ballard Spahr Andrews Ingersoll, LLP.
Jennifer Miller is a partner in the Business & Finance Department of Ballard Spahr where she specializes in securities, corporate finance, strategic alliances, pharmaceutical and biotechnology licensing, technology transfers, mergers and acquisitions. Ms. Miller also handles transactions in the venture capital and seed investment arena and has worked with a number of private and public, multinational pharmaceutical and biotechnology companies. Prior to joining Ballard Spahr, Ms. Miller served as Wolcott clerk to the Honorable Andrew G.T. Moore of the Supreme Court of Delaware. Jennifer is a graduate of Widener Law School and is licensed to practice in Pennsylvania and New Jersey.
“Early Stage East's Bio · Life · Tech is the region's premier forum for young life science companies. It is a great way for them to meet and network with venture capitalists, angel investors and other professionals,” said Steve Simpson, Partner with Ernst & Young.
Steve Simpson is a partner in the Philadelphia Strategic Growth Markets Practice of Ernst & Young. Steve has over fifteen years of experience working with both publicly and privately held domestic and international corporations and is fully devoted to serving clients in the life sciences industry. He has extensive experience in accounting and auditing services, financial reporting, Securities and Exchange Commission registration statements and reporting, initial and secondary public offerings, private offerings and advisory services related to mergers and acquisitions and transaction support.
Steve graduated from Villanova University in 1991 and is a member of the American and Pennsylvania Institutes of Certified Public Accountants.
“Traditionally we have held our Bio-Life-Tech Princeton event in the life science corridor in the southern end of our footprint. We are looking forward to working with some of the investors in the Princeton area as well as some of our new partners in New York,” said Amy Aiq, Director of Early Stage East.
Bio-Life-Tech Princeton focuses on early stage companies involved in life science, biotechnology, pharmaceutical, medical instrumentation and the related emerging technologies. The conference will bring 200+ entrepreneurs, CEO's, VC's and investors together in one the East Coast's hot beds of life science innovation and investment.
Apply to present at the conference or register to attend at www.earlystageeast.org. The deadline to apply is October 30th.
Sponsorships are still available, but selling out quickly. Learn more about sponsorship opportunities by contacting the Early Stage East office as soon as possible at 302-777-2460 or [email protected].
About Ballard Spahr Andrews & Ingersoll, LLP
Ballard Spahr Andrews & Ingersoll, LLP is a national law firm with nearly 500 lawyers in ten offices in the mid-Atlantic corridor and the western United States . Ballard Spahr's broad scope of practices includes more than 30 specialty groups with strong local market knowledge that provide cutting-edge representation for corporate, institutional, entrepreneurial, and individual clients. Ballard's Biotechnology and Life Sciences Group has a long history of counseling and negotiating on behalf of the life sciences industry, including biotechnology and pharmaceutical companies, medical and academic research institutions and health care providers, contract research organizations, medical device manufacturers, and investment banking and venture capital firms focused on this industry.
About Ernst & Young
Ernst & Young is a global leader in professional services with over 107,000 people in 140 countries that provide a range of sophisticated services centered on their core competencies of auditing, accounting, tax and transactions. The Strategic Growth Markets practice at Ernst & Young works with dynamic, high-growth companies that aim to be the national and multinational leaders of the future. By focusing on solutions, such as cash flow management, accelerating global growth, expanding infrastructure, as well as by addressing tax issues, Ernst and Young has helped new businesses transform themselves into many of today's Fortune 500 companies.
About Early Stage East
Early Stage East is an organization dedicated to seeing early stage companies grow and succeed. Early Stage East was founded in 1998 as a non-profit organization and has grown from a single-day venture capital fair to a year-round series of events that include venture conferences and entrepreneurial education programs. Our events showcase entrepreneurs from up and down the East Coast, allowing them to effectively obtain venture capital and successfully start break-away businesses. Early Stage East is geographically the largest venture conference tailored specifically for early stage companies. Companies that have participated in Early Stage East events have gone on to raise over $600 million in institutional funding.
|
